Ex Parte Perez-Velazquez et alDownload PDFPatent Trial and Appeal BoardNov 15, 201713667317 (P.T.A.B. Nov. 15, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/667,317 11/02/2012 Jose Luis Perez-Velazquez K8000592US2 7199 34236 7590 11/17/2017 Cowling WLG (Canada) LLP 50 QUEEN STREET NORTH, STE. 1020 P.O. BOX 2248 KITCHENER, ON N2H6M2 CANADA EXAMINER RAMACHANDRAN, VASUDA ART UNIT PAPER NUMBER 3735 NOTIFICATION DATE DELIVERY MODE 11/17/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): VAL.COTTRILL@GOWLINGWLG.COM Waterloo.IP@gowlingwlg.com JEFF.WONG@GOWLINGWLG.COM PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte JOSE LUIS PEREZ-VELAZQUEZ, VERA NENADOVIC, and LUIS GARCIA DOMINGUEZ Appeal 2015-008135 Application 13/667,317 Technology Center 3700 Before MICHAEL C. ASTORINO, AMEE A. SHAH, and ROBERT J. SILVERMAN, Administrative Patent Judges. ASTORINO, Administrative Patent Judge. DECISION ON APPEAL The Appellants appeal under 35 U.S.C. § 134 from the Examiner’s decision rejecting claims 1—12. We note that the Appellants present the following as additional evidence: Declaration of Jose Luis Perez Velazquez under 37 C.F.R. § 1.132 (“Perez Velazquez Declaration”); Davies Brian and Martin Brian, Numerical Inversion of the Laplace Transform: a Survey and Comparison of Methods, Journal of Computational Physics, Vol. 33, 1—32 (1979); Jose C. Principe and Jack R. Smith, Design and implementation of linear phase FIR fdters for biological signal processing, IEEE Trans Biomed Eng., Vol. BME-33, 6, 550-9 (1986); and Tcheslavski et al., Phase synchrony and coherence analyses of EEC as tools to discriminate between Appeal 2015-008135 Application 13/667,317 children with and without attention deficit disorder, ScienceDirect, Biomedical Signal Processing and Control, 1, 151—161 (2006). See Appeal Br. 28, Evidence App. We have jurisdiction over the appeal under 35 U.S.C. § 6(b). We AFFIRM. STATEMENT OF THE CASE Subject Matter on Appeal The Appellants’ “invention relates generally to methods of diagnosis and prognosis with respect to conditions of the pediatric brain, including brain injury and coma, based on fluctuations in cortical synchronization.” Spec. 12. Claims 1,11, and 12 are the independent claims on appeal. Claim 1, reproduced below, is illustrative of the subject matter on appeal. 1. A computer-implemented method of prognosis in a pediatric patient in a coma comprising the steps of: a) evaluating, in a processing device, phase synchronization patterns in a first electroencephalogram signal, or a portion thereof, obtained on a patient subsequent to the onset of coma; b) evaluating, in a processing device, phase synchronization patterns in a second electro[en]cephalogram signal, or portion thereof, obtained on the patient at a time subsequent to obtaining the first signal; c) calculating, in a processing device, the temporal variability of the synchronized patterns of the first electroencephalogram signal and of the second electroencephalogram signal and comparing the temporal variability within the synchronized pattern of the first electroencephalogram signal with the temporal variability within synchronized pattern of the second 2 Appeal 2015-008135 Application 13/667,317 electroencephalogram signal, wherein an increase in the temporal variability within the synchronized pattern of the second signal in comparison to the temporal variability within the synchronized pattern of the first signal is indicative of an improvement in the patient. Rejections I. Claims 1—12 stand rejected under 35 U.S.C. § 101 as directed to non-statutory subject matter. II. Claims 1—12 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Nenadovic et al., Fluctuations in Cortical Synchronization in Pediatric Traumatic Brain Injury, (Journal of Neurotrauma, Vol. 25, 615— 627, (2008)) (“Nenadovic”), as evidenced by Miyata et al. (US 4,254,779, iss. Mar. 10, 1981) (“Miyata”).1 ANALYSIS Rejection I The Appellants argued claims 1—12 as a group. See Appeal Br. 5—12. We select claim 1 as the representative claim for this group. Claims 2—12 stand or fall with claim 1. 37 C.F.R. § 41.37(c)(l)(iv). Under 35 U.S.C. § 101, an invention is patent-eligible if it claims a “new and useful process, machine, manufacture, or composition of matter.” 35 U.S.C. § 101. The Supreme Court, however, has long interpreted § 101 1 Although the Examiner does not include claim 5 in the statement of the ground of rejection (Non-Final Act. 5), the Examiner does reject claim 5 under this ground of rejection (id. at 8). The Examiner’s failure to include claim 5 in the statement of the ground of rejection is merely a minor oversight. 3 Appeal 2015-008135 Application 13/667,317 to include an implicit exception: “[l]aws of nature, natural phenomena, and abstract ideas are not patentable.” See, e.g., Alice Corp. Pty. Ltd. v. CLS BankInt7, 134 S. Ct. 2347, 2354 (2014). The Supreme Court, in Alice, reiterated the two-step framework previously set forth in Mayo Collaborative Services v. Prometheus Labs., Inc., 132 S. Ct. 1289, 1300 (2012), “for distinguishing patents that claim laws of nature, natural phenomena, and abstract ideas from those that claim patent-eligible applications of those concepts.” Alice Corp., 134 S. Ct. at 2355. The first step in that analysis is to “determine whether the claims at issue are directed to one of those patent-ineligible concepts” (e.g., to an abstract idea). Id. If the claims are not directed to a patent-ineligible concept, the inquiry ends. Otherwise, the inquiry proceeds to the second step where the elements of the claims are considered “individually and ‘as an ordered combination”’ to determine whether there are additional elements that “‘transform the nature of the claim’ into a patent-eligible application.” Alice Corp., 134 S. Ct. at 2355 (quoting Mayo, 132 S. Ct. at 1297). This is a search for an “inventive concept”—an element or combination of elements sufficient to ensure that the claim amounts to “significantly more” than the abstract idea itself. Id. The Court acknowledged in Mayo that “all inventions at some level embody, use, reflect, rest upon, or apply laws of nature, natural phenomena, or abstract ideas.” Mayo, 132 S. Ct. at 1293. Therefore, the Federal Circuit has instructed that claims are to be considered in their entirety to determine “whether their character as a whole is directed to excluded subject matter.” McRO, Inc. v. Bandai Namco Games Am. Inc., 837 F.3d 1299, 1312 (Fed. 4 Appeal 2015-008135 Application 13/667,317 Cir. 2016) (quoting Internet Patents Corp. v. Active Network, Inc., 790 F.3d 1343, 1346 (Fed. Cir. 2015)). Turning to the first step of the Alice framework, we find supported and agree with the Examiner that claim 1 “merely amount[s] to the concept of providing a prognosis of a pediatric patient in coma as performed by a generic computer,” (Ans. 11), which includes “evaluating and calculating steps which technically can be performed either mentally or by hand,” i.e., mental steps (Final Act. 3). Indeed, the preamble of claim 1 provides that the claim is for “[a] method of prognosis in a pediatric patient in a coma.” Appeal Br. 23, Claims App. As stated in the Specification, “[t]he present invention relates generally to methods of diagnosis and prognosis with respect to conditions of the pediatric brain, including brain injury and coma, based on fluctuations in cortical synchronization.” Spec. 12. For example, the Specification describes a patient’s “emergence from coma” as a “good prognosis.” Id. at 137. The abstract idea here is similar to certain steps that can be performed in the mind of a designer or by a designer using pen and paper, and therefore the claim is directed to an abstract mathematical algorithm that represents mental processes. See In re Meyer, 688 F.2d 789, 794—95 (CCPA 1982); see also In re Grams, 888 F.2d 835, 840-41 (Fed. Cir. 1989). The Appellants argue, “after taking all of the claim recitations into consideration, the Appellants’ invention presents functional and palpable applications in the field of computer technology in which a computer performs steps in memory by a processor to achieve results outside of the ordinary function of a computer under comparable circumstances.” Appeal Br. 10. The Appellants assert that the Specification at paragraph 36 shows 5 Appeal 2015-008135 Application 13/667,317 that “the inventors have, for the first time, transformed phase synchronized EEG signals into ‘temporal variability’ defined as 'the variance of a temporal sequence of synchrony values[,f and have determined that temporal variability is related to prognosis of pediatric coma patients.”2 Id. at 10—11. The Appellants’ argument is not persuasive of Examiner error. The Specification at paragraph 36 is not directed to applications in the field of computer technology, rather it is directed to the use of a mathematical algorithm to evaluate patient’s condition. See Ans. 11. A case that offers a close comparison is In re Grams, 888 F.2d 835 (Fed. Cir. 1989), where the claims found patent ineligible were directed to a process that involved (1) performing a clinical test on individuals and (2) based on the data from that test, determining if an abnormality existed and determining possible causes of any abnormality by using an algorithm. The Federal Circuit found the process was not drawn to patent-eligible subject matter because the essence of the claimed process was the mathematical algorithm (an abstract idea), as it is here. In re Grams, 888 F.2d at 839-41. The Appellants argue that claim 1 “does not merely define an abstract idea;” rather “claim 1 includes physical process steps of ‘evaluating’, ‘calculating’, [and] ‘comparing’ . . . that transform electroencephalogram signals into temporal variability that is used in a determination of coma patient prognosis.”3 Appeal Br. 11 (emphasis added). The Appellants’ argument suggests that the steps of “evaluating,” “calculating,” and 2 Although the Appellants cite to the Specification at 34 for the definition of the term “temporal variability,” the quotation is taken from paragraph 36. 3 The Appellants assert that claim 1 includes a step of determining. Appeal Br. 11. However, claim 1 does not include a step of determining. See id. 6 Appeal 2015-008135 Application 13/667,317 “comparing” are “physical” because of “a specific way of ‘doing something with a computer.’” See id. at 11—12. The Appellants assert that “[t]he structure of Appellants’ claims require complex programming to enable the transformation of phase synchronized EEG signals into ‘temporal variability.’” Id. at 12. Similarly, the Appellants contend that “determining a prognosis for a coma patient of Appellants’ claims are achieved first by a special purpose computing system that includes a processing device coupled to a an EEG device or sensor or that is configured to read EEG signals from a storage medium or network.” Reply Br. 7—8 (citing Spec. 33—39). The Appellants’ argument is not persuasive of Examiner error. The Appellants fail to point out language in claim 1 that requires a specific way of doing something with a computer. To the extent that claim 1 recites the performance of the evaluating and calculating steps “in a processing device,” the Specification instructs us that the processing device is a generic computer. See Non-Final Act. 3^4; Ans. 12. Indeed, the Specification describes, among other things, “[t]he methods described herein may be implemented using any suitable processing device, including any suitable computer or microprocessor-based system, such as a desktop or laptop computer or a mobile wireless telecommunication computing device, such as a smartphone or tablet computer, which may receive the electroencephalogram signals.” Spec. 139; see also id. 140, 43^44, Figs. 7 A—B. As the Federal Circuit has made clear “the basic character of a process claim drawn to an abstract idea is not changed by claiming only its performance by computers, or by claiming the process embodied in program instructions on a computer readable medium.” See CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d, 1366, 1375—76 (Fed. Cir. 2011) (citing In 7 Appeal 2015-008135 Application 13/667,317 reAbele, 684 F.2d 902 (CCPA 1982)); see also Alice, 134 S. Ct. at 2357—60 (applying an abstract idea, such as an algorithm, on a general purpose computer is not enough to transform a patent-ineligible abstract idea into a patent-eligible invention); EON Corp. IP Holdings LLC v. AT & TMobility LLC, 785 F.3d 616, 623 (Fed. Cir. 2015) (“A microprocessor or general purpose computer lends sufficient structure only to basic functions of a microprocessor. All other computer-implemented functions require disclosure of an algorithm.”). Furthermore, under the second part of the Alice analysis, we find supported and agree with the Examiner’s determination that, considering the claim elements individually as an ordered combination, claim 1 does not amount to “significantly more” than the abstract idea itself. Final Act. 3—4, Ans. 11. The Appellants do not provide adequate evidence or technical reasoning that claim 1 — when considered individually and as an ordered combination — improves some existing technological process or solves some technological problem in conventional industry practice. Versata Dev. Grp., Inc. v. SAP Am., Inc., 793 F.3d 1306, 1334 (Fed. Cir. 2015) (finding that the “claims recit[ed] a commonplace business method aimed at processing business information despite being applied on a general purpose computer.”), cert, denied, 136 S. Ct. 2510 (2016). In other words, claim 1 does not amount to “significantly more” than the mathematical algorithm that represents mental processes, the abstract idea itself. Thus, we sustain the Examiner’s rejection of claims 1—12 as directed to non-statutory subject matter under 35 U.S.C. § 101. 8 Appeal 2015-008135 Application 13/667,317 Rejection II The Appellants argue claims 1—12 as a group. See Appeal Br. 12—22. We select claim 1 as the representative claim for this group. Claims 2—12 stand or fall with claim 1. 37 C.F.R. § 41.37(c)(l)(iv). The Appellants argue that the Examiner’s rejection of claim 1 under 35 U.S.C. § 103(a) as unpatentable over Nenadovie, as evidenced by Miyata, is legally flawed because Nenadovic is not prior art under 35 U.S.C. § 102. Appeal Br. 13. The Appellants argue that Nenadovic, which was published in June 2008, post-dates the present application’s effective filing date of May 14, 2008.4,5 Appeal Br. 13. The Examiner determines that claim 1 is not entitled to an earlier filing date because it “recite[s] ‘a processing device,”’ which is not supported by the earlier non-provisional application 12/453,528 and the earlier provisional application 61/071,721 (hereinafter, “earlier applications”), to which the Appellants claim priority.4 5 6 See Non-Final Act. 3; Ans. 15. Accordingly, the Examiner determines that claim 1 is only entitled the filing date of the present application, which is November 2, 2012. See Non-Final Act. 3. 4 The present application “is a continuation-in-part to U.S. Application Serial No. 12/453,528 filed on May 14, 2009, which claims priority to U.S. Provisional Application No. 61/071,721 filed on May 14, 2008.” Spec. 11. 5 The Appellants assert that “the present application is entitled to at least the filing date of U.S. Patent Application S/N 61/071,721 and U.S. Patent Application S/N 12/453,528 as set forth in 35 U.S.C. § 120.” Appeal Br. 13. 6 The published parent application of the earlier non-provisional application 12/453,528 is Perez-Velazquez et al. (US 2010/0022907 Al, pub. Jan. 28, 2010) (“Perez-Velazquez”). 9 Appeal 2015-008135 Application 13/667,317 The Appellants argue that “the claims of Appellants’ patent application are supported by the underlying patent application so as to satisfy the written description requirement of 35 U.S.C. § 112, first paragraph,” and thus be entitled to an earlier date than the filing date of the present application. Reply Br. 9; see Appeal Br. 13—14. Indeed, claim 1 would be entitled to the benefit of an earlier filing date if the subject matter of the claims is disclosed in the earlier applications in the manner provided by 35 U.S.C. § 112, first paragraph. See 35 U.S.C. § 120. To satisfy the written description requirement, “the [original] specification must describe an invention understandable to that skilled artisan and show that the inventor actually invented the invention claimed.” AriadPharms., Inc. v. EliLilly & Co., 598 F.3d 1336, 1351 (Fed. Cir. 2010) (en banc). “[T]he test for sufficiency is whether the disclosure of the application relied upon reasonably conveys to those skilled in the art that the inventor had possession of the claimed subject matter as of the filing date.” Id. (citations omitted); see also MPEP § 2163 (3)(b) (“When an explicit limitation in a claim ‘is not present in the written description whose benefit is sought it must be shown that a person of ordinary skill would have understood, at the time the patent application was filed, that the description requires that limitation.’ Hyatt v. Boone, 146 F.3d 1348, 1353, . . . (Fed. Cir. 1998).”). “And[,] while the description requirement does not demand any particular form of disclosure, or that the specification recite the claimed invention in haec verba, a description that merely renders the invention obvious does not satisfy the requirement.” Ariad, 598 F.3d at 1352 (citations omitted). 10 Appeal 2015-008135 Application 13/667,317 After carefully considering the arguments presented in the Appeal Brief at pages 12—22 and the Reply Brief at pages 8—11, we agree with the Examiner that claim 1 is not entitled to an earlier filing date because the claim recites the phrase, “in a processing device” with regard to the evaluating and calculating steps. In this case, we determine that the disclosure of the earlier applications do not reasonably convey to those skilled in the art that the Appellants had possession of the claimed subject matter as of the filing date. We make this determination for reasons expressed by the Examiner in the Answer at pages 12—15, and adopt them as our own. For example, in the Answer the Examiner explains, “it is well- known to calculate phase changes and synchronization in signals by hand,” so “the use of a processor is not the necessary and only reasonable way of computing variability in an EEG signal.” Ans. 13. Accordingly, we determine that Nenadovic is a valid prior art reference under 35 U.S.C. §102 because Nenadovic was published in June 2008, which is prior to the filing date (i.e., November 2, 2012) of the present application. Turning to some of the Appellants’ specific contentions, the Appellants do not argue that the disclosure in the earlier applications explicitly or inherently show possession of the claimed subject matter; rather, the Appellants argue that possession of the claimed invention is demonstrated by statements in the earlier applications that we regard as vague and inadequate. For example, the Appellants refer to a description concerning the state of the art (the Background of the Invention), i.e., “[sjynchrony analysis, specifically phase synchronization based on the analytic signal approach, has evolved as the power and utility of computers has improved, and is now 11 Appeal 2015-008135 Application 13/667,317 more sophisticated than previous analysis of coherence.” Appeal Br. 15 (quoting Perez-Velazquez | 5). Initially, we note that this description concerns the state of the art, rather than the Appellants’ invention. And, as the Examiner finds, “it is well-known to calculate phase changes and synchronization in signals by hand,” so “the use of a processor is not the necessary and only reasonable way of computing variability in an EEG signal.” Ans. 13. Similarly, the Appellants refer to a description in the earlier application in the Detailed Description of the Invention, i.e., “[p]hase synchronization of EEG signals is determined using signal transformations. Initially, a selected region of each EEG signal is processed to provide a reference-free signal, for example using a Laplacian transform.” Appeal Br. 15—16 (quoting Perez-Velazquez 128); see also id. at 20-21 (citing Perez-Velazquez || 33, 34, 46, 56, and Fig. 5). However, the term “processed” does not provide a reference to what or who is performing the processing. See Ans. 14. As the Examiner finds, “the term ‘processed’ is not limited to computers and can be applied to a variety of processes. For example, a person can process the information obtained from an EEG signal in their head.” Id. The Appellants include additional evidence, by way of journal articles and the Perez Velazquez Declaration, to bolster their argument. Supra. However, the cited disclosure in the earlier applications and the additional evidence — when weighed together — does not support the Appellants’ argument. Rather, it supports the notion that performance of the evaluating and calculating steps of claim 1, “in a processing device,” was obvious; and, 12 Appeal 2015-008135 Application 13/667,317 “a description that merely renders the invention obvious does not satisfy the requirement.” Ariad, 598 F.3d at 1352 (citations omitted). Lastly, the Appellants assert that “the Examiner has not rejected any of Appellants’ claims under 35 U.S.C. § 112, first paragraph.” Reply Br. 10 (emphasis omitted). This is of no consequence. The present application is a continuation-in-part (Spec. 11) and adds disclosure to the Specification which reasonably conveys to those skilled in the art that the inventor had possession of the claimed subject matter, which has a filing date of November 2, 2012. See, e.g., id. Tflf 39-40, 43^44. Thus, we sustain the Examiner’s rejection of claims 1—12 under 35 U.S.C. § 103(a). DECISION We AFFIRM the Examiner’s decision rejecting claims 1—12. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(l)(iv). AFFIRMED 13 Copy with citationCopy as parenthetical citation